FreyK.: Internal report from the Analytical Department of Nyegaard & Co. A/S, Oslo, Norway, dated 21 February, 1967.
2.
FreyK. Thin-layer chromatography of 126I-labelled metrizamide in urine from laboratory animals. Acta radiol. (1973) Suppl. No. 335, p. 286.
3.
GolmanK. (a): Excretion of metrizamide. Parts I, II, III and IV. Acta radiol. (1973) Suppl. No. 335, p. 253, 258, 264, 268.
4.
GolmanK. (b) Distribution and retention of 125I-labelled metrizamide. after intravenous and suboccipital injection in rabbit, rat and cat. Acta radiol. (1973) Suppl. No. 335, p. 300.
5.
HaavaldsenJ.LundeG.: The synthesis of 125I-labelled 2-(3-acetamido-5-N-methyl-acetamido-2,4,6-triiodobenzamido)-2-deoxy-D-glucose. To be published in Acta chem. scand.
6.
McChesneyE. W.: The biotransformation of iodinated radiocontrast agents. In:Radiocontrast agents. First edition, p. 147. Pergamon Press Ltd., London1971.
7.
NordalV.HaavaldsenJ.KellyM.FreyK.HoltermannH.: To be published.
8.
SalvesenS.: Suboccipital injection of metrizamide to anaesthetized and unanaesthetized rabbits. Acta radiol. (1973) Suppl. No. 335, p. 93.
9.
TengC. T.KaramourtjournisJ.: Quantitative effect of iodinated opaque media on thyroidal uptake of radioiodine. Amer. J. Roentgenol.83 (1960), 491.
10.
WilliamsR. T.: Comparative patterns of drug metabolism. Fed. Proc.26 (1967), 1029.